Skip to content

Dihexa

Neuroprotective hexapeptide. Synaptogenic, hepatocyte growth factor receptor agonist. Cognitive enhancement, neurogenesis. 10 million times more potent than BDNF in synapse formation.

Intelligence Profile

Science

Mechanism of Action

Dihexa is an angiotensin IV analog that appears to work through multiple molecular pathways, though the evidence for its mechanisms remains limited and primarily derived from preclinical studies.

Primary Mechanism - PI3K/AKT Signaling:
The most well-characterized mechanism comes from a 2021 study in APP/PS1 mice (a model of Alzheimer's disease), which found that dihexa activates the PI3K/AKT signaling pathway. This pathway is crucial for cell survival, growth, and synaptic plasticity - processes that are impaired in neurodegenerative conditions. The study demonstrated that dihexa treatment led to cognitive improvement and memory recovery in these mice through this signaling cascade.

Angiotensin System Modulation:
As an angiotensin IV analog, dihexa likely interacts with components of the renin-angiotensin system in the brain. A 2018 systematic review noted cognitive benefits associated with angiotensin IV and related peptides, suggesting this system plays a role in memory and learning processes. However, the specific receptors and downstream effects of dihexa within this system are not clearly established in the available evidence.

Cellular Differentiation Effects:
Multiple studies from 2015-2022 indicate dihexa may influence stem cell differentiation, particularly in hepatocyte development from pluripotent stem cells. This suggests the compound may have broader effects on cellular development and regeneration pathways, though the clinical relevance of these findings remains unclear.

Neuroprotective Properties:
A 2024 study in a rat model of Huntington's disease showed dihexa provided protection against 3-nitropropionic acid-induced neuronal damage, suggesting additional neuroprotective mechanisms beyond the PI3K/AKT pathway.

Evidence Limitations:
It's important to note that the available evidence comes entirely from animal studies and in vitro research. The precise molecular targets, optimal dosing, and safety profile in humans remain largely unknown, as no human clinical trials were identified in the literature search.